Complement Factor H Polymorphism, Complement Activators, and Risk of Age-Related Macular Degeneration
Author(s) -
Dominiek D. G. Despriet,
Caroline C. W. Klaver,
Jacqueline C.M. Witteman,
Arthur A. Bergen,
Isabella Kardys,
Moniek P.M. de Maat,
Sharmila S. Boekhoorn,
Johannes R. Vingerling,
Albert Hofman,
Ben A. Oostra,
André G. Uitterlinden,
Theo Stijnen,
Cornelia M. van Duijn,
Paulus T.V.M. de Jong
Publication year - 2006
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.296.3.301
Subject(s) - medicine , factor h , macular degeneration , odds ratio , confidence interval , rotterdam study , population , allele , hazard ratio , c reactive protein , risk factor , prospective cohort study , immunology , complement system , inflammation , genetics , ophthalmology , gene , biology , antibody , environmental health
The evidence that inflammation is an important pathway in age-related macular degeneration (AMD) is growing. Recent case-control studies demonstrated an association between the complement factor H (CFH) gene, a regulator of complement, and AMD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom